Media reports have also flagged Sikiris commercial interest in BPC-157, noting that his patent for a stable version of the compound is for sale
Important 5-Amino-1MQ Research Limitations The evidence is broader than one experiment but remains entirely preclinical
Recalls & Warnings April 10, 2021 Companies Deceived Consumers About Fish Oil for Liver Disease, Says FTC On April 1, 2021, the Federal Trade Commission (FTC) announced that fish oil supplement manufacturer BASF SE and its U.S
Several Substances Get Placed on the Category 2 Bulks List The following substances were added to Category 2 because FDA claimed to identify significant safety risks: AOD 9604 BPC-157 Cathelicidin LL-37 CJC-1295 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) Ibutamoren Mesylate Ipamorelin Acetate Kisspeptin-10 KPV Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF) MOTs-C Selank Acetate (TP-7) Semax (heptapeptide) Thymosin Alpha-1 (Ta1) Thymosin Beta-4, Fragment (LKKTETQ) Compounding Industry Group Initial Response In early October, Scott Brunner from the Alliance for Pharmacy Compounding (APC) commented on the updates, particularly noting the addition of certain peptides to Category 2
Document what was assessed, what clinical decision was made, and how that decision differed from the injection administration work
The Scoop on NAD+ Nicotinamide adenine dinucleotide (NAD) is a coenzyme that is required for over 500 enzymatic reactions and plays a key role in the regulation of almost all major biological processes
&srotate=0)
